Abstract
For more than thirty years, Belgium, the Netherlands, and Luxembourg have been promoting the free flow of capital, goods, and services across their borders under the Benelux agreement. In keeping with the spirit of this arrangement is the Joint Benelux Service for Registration of Drugs, a step toward the ultimate aim of complete centralization of drug registration in Benelux. At present, the national agencies must seek and abide by the advice of this group when deciding on the marketing application for a drug with an active principle not previously approved.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bogaert, M. (1981). Harmonization of Regulatory Requirements: Centralization in the Benelux Countries. In: Wardell, W.M., Velo, G. (eds) Drug Development, Regulatory Assessment, and Postmarketing Surveillance. NATO Advanced Study Institutes Series, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4055-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4055-3_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4057-7
Online ISBN: 978-1-4684-4055-3
eBook Packages: Springer Book Archive